U.S. Biotech Stock News

In recent days, Inspire Medical Systems has faced renewed attention as regulators finalized a substantial future increase in Medicare facility fees for its sleep apnea procedure, while multiple law firms advanced securities class actions tied to the rollout of its Inspire V device. This combination of richer long-term reimbursement and heightened legal and execution scrutiny creates a complex risk–reward backdrop for investors assessing Inspire’s path forward. Now we’ll explore how the...

Bit Digital, Inc. recently disclosed that director Xiashu “Bill” Xiong will resign effective January 1, 2026, while long-time chair Zhaohui Deng shifted to an independent director role and the board appointed crypto executive Amanda Cassatt for a one-year term starting the same day. These boardroom moves coincide with Bit Digital’s expanding Ethereum holdings and staking activity, sharpening investor focus on how fresh governance and crypto expertise might shape the company’s evolving...

On December 5, 2025, Graco Inc. announced a 7.3% increase in its regular quarterly dividend to US$0.295 per share, payable on February 4, 2026, and unveiled a new repurchase authorization for up to 15,000,000 shares with no set expiry. By simultaneously raising its cash payout and committing to a large, open-ended buyback, Graco is signaling confidence in its balance sheet and willingness to return more capital directly to shareholders. Next, we’ll examine how Graco’s larger quarterly...

Dropbox, Inc. announced that longtime finance chief Timothy Regan has stepped down as CFO after five years in the role, with former Avalara president and ex-CFO Ross Tennenbaum taking over on December 16, 2025, as Regan remains at the company in a non-executive capacity until March 15, 2026. This leadership change comes as Dropbox increases spending on artificial intelligence, including its Dropbox Dash tool that links services like Google Workspace and Slack to organize and search files...

Earlier in December 2025, CVS Health raised its 2025 guidance to at least US$400.00 billion in revenue and higher GAAP operating income, while also flagging an expected US$5.73 billion goodwill impairment tied to its health care delivery assets. The combination of upgraded guidance and a very large non-cash impairment highlights how CVS is resetting reported earnings while doubling down on value-based care and its Healthy 2030 sustainability agenda. We’ll now examine how this mix of higher...

Earlier this month, The Progressive Corporation’s board declared a quarterly dividend of US$0.10 per share and a much larger annual dividend of US$13.50 per share, both payable on January 8, 2026, to shareholders of record on January 2, 2026. These dividend decisions came alongside November 2025 results showing double‑digit growth in net premiums written and earned, plus an 87.1 combined ratio that underscores currently efficient underwriting. With this strong premium growth and underwriting...

Thermon Group Holdings (THR) has quietly turned into a strong compounder, with the stock up about 38% over the past 3 months and roughly 90% over the past 3 years. See our latest analysis for Thermon Group Holdings. The latest 30 day share price return of 11.05 percent and 90 day share price return of 38.06 percent, capped by a three year total shareholder return near 90 percent, suggests momentum is still firmly building even after the recent pullback to 37.40 dollars. If Thermon’s run has...

SL Green Realty Corp. recently announced that its board declared a regular quarterly cash dividend of US$0.40625 per share on its Series I Preferred Stock for the period from October 15, 2025 to January 14, 2026, payable on January 15, 2026 to shareholders of record as of December 31, 2025. Alongside this, the company reported signing 2.3 million square feet of Manhattan office leases so far in 2025, with a further 1.2 million square feet in its pipeline, underscoring how active leasing...

Market context and recent performance Nektar Therapeutics (NKTR) has quietly turned into a high volatility story stock, with shares up more than 200% over the past year even as the past month has been choppy. See our latest analysis for Nektar Therapeutics. That surge has come with a reality check, as the 30 day share price return of negative 23.22% and recent weekly pullback suggest some speculative heat is cooling even though the 1 year total shareholder return remains exceptionally...

Earlier this week, Canaccord Genuity reaffirmed its positive rating on Artivion, citing the growth potential of the company’s On-X mechanical heart valve business, supported by two newly published clinical studies favoring mechanical valves for patients aged 65 and under. This combination of supportive clinical evidence and analyst confidence highlights how clinical outcomes data can directly influence perceived demand for Artivion’s core valve portfolio among younger cardiac patients. We’ll...

CoreCivic (CXW) has quietly climbed about 5% this week and 20% over the past month, drawing fresh attention to whether the market is reassessing this prison REIT’s earnings power and policy risk. See our latest analysis for CoreCivic. Zooming out, that 1 month share price return of just over 20% looks more like a sharp rebound within a choppy year, with the stock still down on a year to date share price basis even as its 3 year total shareholder return remains strong. This hints that...

In early December 2025, Olympus, W. L. Gore & Associates, and CONMED announced that US distribution of the GORE VIABIL biliary stent will shift from CONMED to Olympus on January 1, 2026, as CONMED accelerates the end of its Gore distribution agreement. At the same time, CONMED confirmed it will exit its gastroenterology product lines to focus resources on minimally invasive, robotic, and orthopedic soft tissue surgery, aligning its portfolio more tightly with its core areas. Now, we will...

Kimbell Royalty Partners, LP recently completed its Fall 2025 borrowing base redetermination and entered a Second Amended and Restated Credit Agreement, extending its secured revolving credit facility’s maturity to December 16, 2030, reaffirming a US$625 million borrowing base, cutting interest spreads by 35 basis points, and lifting the maximum facility size to US$1.50 billion. The unanimous support from existing lenders, combined with lower borrowing costs and looser covenants, signals...

Earlier this week, Wedbush initiated coverage on Rithm Capital Corp. with an Outperform rating, pointing to its valuation, consistent dividend history, and the recent Crestline Management acquisition that lifted its investable assets to about US$102 billion. The endorsement also drew attention to the firm’s growing investment advisor arm and expansion in alternative lending, reinforcing Rithm’s push to become a broader real-asset and credit manager rather than a traditional mortgage REIT...

WesBanco (WSBC) has quietly put together a solid run, with the stock up roughly 16% over the past month. That climb comes alongside double digit revenue and earnings growth and is drawing fresh attention to its valuation. See our latest analysis for WesBanco. Zooming out, WesBanco’s 30 day share price return of about 16% has helped lift year to date gains and sits alongside a five year total shareholder return of roughly 47%. This suggests momentum is building as investors warm to its growth...

In recent days, Spire Global announced it secured a place on the Missile Defense Agency’s SHIELD IDIQ contract with a ceiling of US$151.00 billion and expanded its AI-driven Power Generation Forecasts into the ERCOT power market using its satellite-enhanced weather and RF data capabilities. These moves highlight how Spire is leaning on its fully deployed satellite constellation and AI weather platform to deepen exposure to U.S. defense and renewable energy customers at the same time. We’ll...

Andersen Group (ANDG) shares edged higher today, and investors are starting to ask whether this quiet move is the start of a new trend or just short term noise. See our latest analysis for Andersen Group. Today’s 1 day share price return of 46.88% at a closing share price of $23.5 marks a sharp break higher for Andersen Group, hinting that investors are rapidly repricing its growth and risk profile after a relatively muted year to date. This suggests early signs of building momentum rather...

Earlier this week, Fulton Financial Corporation’s Board of Directors increased its quarterly common dividend to US$0.19 per share and confirmed a quarterly preferred dividend, both payable on January 15, 2026, while also approving a new US$150 million capital return program spanning common shares, preferred stock and certain subordinated notes. These moves reinforce the bank’s emphasis on returning cash to investors through a higher regular payout and flexible repurchases across its capital...

Coursera (COUR) shares have quietly slid about 32% over the past 3 months, even as its revenue and net income trend higher. This has created an interesting gap between business progress and market sentiment. See our latest analysis for Coursera. Over the past year, Coursera’s share price return has softened, with the recent 90 day slide to about $7.84 suggesting investors are reassessing near term execution risk, even as revenue and net income continue to improve. If Coursera’s recent...

If you have ever wondered whether Walmart is still a buy at these levels, you are not alone. This is exactly the question we are going to unpack. Walmart's share price has climbed 2.2% over the last week, 12.3% over the last month, and is up 28.5% year to date, capping a run where the stock has gained 159.3% over five years. Investors have been reacting to Walmart's continued push into higher margin areas like advertising and membership driven services, as the company leans further into its...

Honeywell International (HON) has been getting extra attention after Evercore ISI kicked off coverage with an upbeat view, just as the company pushes ahead with major portfolio separations and high profile technology partnerships. See our latest analysis for Honeywell International. The upbeat coverage and new partnerships seem to be nudging sentiment in Honeywell’s favour, with a 7 day share price return of 4.08% helping to offset a weaker year to date share price return of 11.36%. The 5...

Verizon Communications (VZ) has been quietly grinding higher, with shares up about 2% over the past week even as the past 3 months remain slightly negative. That mix sets up an interesting value discussion. See our latest analysis for Verizon Communications. Zooming out, Verizon’s 1 year total shareholder return of 8.58% and 3 year total shareholder return above 30% suggest improving sentiment, even though the current share price of $40.88 still reflects modest expectations. If Verizon’s...

Marriott International (MAR) just hit a key milestone in its midscale push, locking in 100 signed City Express by Marriott deals across the U.S. and Canada, plus new entries planned for Osaka, Japan. See our latest analysis for Marriott International. Investors seem to be leaning into that midscale growth story, with a roughly 17 percent 3 month share price return and a powerful 5 year total shareholder return near 150 percent suggesting momentum remains firmly on Marriott’s side. If this...

Rollins (ROL) just delivered record third quarter revenue with better margins, and that, paired with a fresh rating upgrade, has given the stock an extra dose of investor confidence. See our latest analysis for Rollins. The upbeat quarter has landed on top of an already strong run, with the share price up about 30.8% year to date and a three year total shareholder return of roughly 67.6%, suggesting momentum is still very much with Rollins. If Rollins recent climb has you rethinking where...